Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
The spread of coronavirus disease 2019 (COVID-19) throughout the world has resulted in stressful healthcare burdens and global health crises. Developing an effective measure to protect people from infection is an urgent need. The blockage of interaction between angiotensin-converting enzyme 2 (ACE2)...
Saved in:
Main Authors: | Canhao Wu (Author), Qin Xu (Author), Huiyuan Wang (Author), Bin Tu (Author), Jiaxin Zeng (Author), Pengfei Zhao (Author), Mingjie Shi (Author), Hong Qiu (Author), Yongzhuo Huang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]
by: Canhao Wu, et al.
Published: (2023) -
A simple and safe antibody neutralization assay based on polio pseudoviruses
by: Zheng Jiang, et al.
Published: (2019) -
Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
by: Sheng Wang, et al.
Published: (2022) -
Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10
by: Kelei Li, et al.
Published: (2020) -
Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation
by: Zeng Wang, et al.
Published: (2023)